Deuterium oxide as a tracer for measurement of compliance in pediatric clinical drug trials
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 114 (5) , 885-891
- https://doi.org/10.1016/s0022-3476(89)80159-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Stable isotopic abundances as reflections of ingestion practicesControlled Clinical Trials, 1984
- Tracer microspheres as compliance markers in clinical researchControlled Clinical Trials, 1984
- Adherence measures and their utilityControlled Clinical Trials, 1984
- Statement of the problem and pharmacological and clinical requirements for the ideal markerControlled Clinical Trials, 1984
- Riboflavin use as a drug marker in Veterans Administration Cooperative StudiesControlled Clinical Trials, 1984
- Use of stable isotopes to determine complianceControlled Clinical Trials, 1984
- An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.Published by Wiley ,1980
- In Search of the Gold Standard for Compliance MeasurementArchives of internal medicine (1960), 1979
- Precise measurement of total body water using trace quantities of deuterium oxideJournal of Mass Spectrometry, 1977
- Studies with Deuterated DrugsJournal of Pharmaceutical Sciences, 1975